- Supplier site
- Group of sites (click to zoom)
Scientist.com supplier network (site locations)
Research supplier
Tempus AI, Inc.
Tempus AI, Inc. is listed as a large business research supplier in the Scientist.com network, with 3 sites in 1 country.
Sign in to Scientist.com to open this supplier in your organization's marketplace.
Search companies, drugs, suppliers and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Services
What this research supplier says it provides, as listed in the Scientist.com network.
Type of company: Large business
Biomarkers
- Digital Pathology Acquire, manage and interpret pathology information generated from a digital image of a slide preparation of cells or tissue.
- Epigenetics Epigenetics sits at the cutting edge of drug discovery. The ability to modify genomes without changing any sequences with methylation.
- Immunohistochemistry Examine the toxic effects of pre-clinical compounds in small animal and patient histological samples.
- Multi-Omics Study Use an integrated multi-omics study to understand a disease mechanism.
- Single Cell Transcriptome Sequencing Detect distinct, rare or abnomal cell types in a heterogenous population.
- Solid Tumor CDx Design and validate companion diagnostics for solid tumors that help select the most appropriate patients, identify patients at increased risk, or monitor treatment effectiveness.
Show all 7 in Biomarkers
- SomaScan Proteomic Assay Measure 11,000 protein measurements from a 55-µL sample.
Cell Culture and Characterization
- Single Cell Services Request services to perform genomics, transcriptomics, proteomics, metabolomics and cell–cell interactions at the single cell level
Clinical Trials
- Prospective Explorative Studies Conduct a prospective exploratory study to assess the safety and efficacy of a test drug during clinical trials.
Companion Diagnostics
- Cervical Cancer CDx Design and validate companion diagnostics for cervical cancer that help select the most appropriate patients, identify patients at increased risk, or monitor treatment effectiveness.
- Pancreatic Cancer CDx Design and validate companion diagnostics for pancreatic cancer that help select the most appropriate patients, identify patients at increased risk, or monitor treatment effectiveness.
DNA & RNA
- DNA Sequencing Determine the nucleotide sequence of DNA samples.
- Genotyping Examine a DNA sequence to identify specific genetic varients .
- Metagenomic Sequencing Sequence genetic material recovered directly from environmental samples
- Methylation Analysis Determine genomic methylation patterns and analyze methylation in tumors and treated samples.
- RNA Profiling Quantify the expression levels of mRNA transcripts, enabling the determination of gene expression patterns.
- RNA Sequencing Use Next Generation Sequencing techniques to Identify RNA transcripts, examine differential expression patterns and analyze splice variants.
Show all 12 in DNA & RNA
- RNA Sequencing/Resequencing Identify RNA transcripts, examine differential expression patterns and analyze splice variants.
- Single Cell RNA Sequencing Quantify mRNA variants in a single cell.
- Spatial Transcriptomics Determine the sub-cellular localization of mRNA molecules. Use this to identify cellular heterogeneity in tissues, tumors, immune cells and the subcellular distribution of transcripts.
- Total RNA Sequencing Identify novel RNA transcripts and detect gene expression changes.
- Whole Genome Profiling Develop sequence-based physical maps for the assembly of genomes.
- Whole Genome Sequencing Determine the entire genetic make-up of an organism.
Show all 38 services
Human Biological Samples
- HBS Leukemia For requesting HBS Leukemia
- Liquid Biopsy Test and detect either circulating tumor cell-associated biomarkers or circulating tumor DNA.
Old Category HEOR, RWE, Market Access
- Non-Interventional Studies Examine different aspects of drug usage, including efficacy and safety, under real-life conditions.
Protein Sciences
- Proteomics Do large-scale experimental analysis of proteins focused on understanding structure and function.
Real World Evidence & Data
- Clinical Phenotype Data Obtain phenotypic data and observations on patients such as the clinical manifestation of the disease, clinical and behavioral parameters, symptoms, and laboratory test results.
- Real-World Data Acquire real-world data from patients' electronic medical records including clinical information generated during the course of healthcare.
- Real-World Evidence Acquire clinical data from patients' medical records to analyze trends and the frequency of occurrence of different medical conditions.
- Retrospective Exploratory Studies Retrospective exploratory studies
- Secondary Real World Evidence Analyze clinical trial data.
Scientific Data Services
- Bioinformatics Bioinformatics is a powerful method of storing, retrieving and analyzing biological data.
- Marker Analyses Identify associations between genetic markers and traits of interest to determine markers responsible for human diseases.
- Mutation Data Profiling Guide treatment decisions in cancer based on the identification of genomic mutations .
- Omics Informatics Consulting Services for the analysis of large-scale molecular data sets.
- Pharmaco-genomics Genetic polymorphism contribution to inter-individual variability in drugs' responses and/or adverse events.
Other services
- Observational Research Gain valuable insights into the association between a drug treatment and its outcomes such as long-term effectiveness and safety.
Where it operates
Sites by country, with the cities in each.
-
United States 3 sites
About this supplier
In the supplier's own words, as listed in the Scientist.com network.
Tempus is a technology company that is building the world's largest library of molecular and clinical data and an operating system to make that data accessible and useful. We aggregate and structure clinical records, pathology images and radiology scans to uncover phenotypic, therapeutic and outcomes data for every patient. Our genomic tests analyze DNA and RNA data to understand a patient's tumor at a molecular level and uncover more personalized treatment options. Our platform analyzes thousands of clinical and molecular data points supporting our partners with actionable insights...
Show the full description
Tempus is a technology company that is building the world's largest library of molecular and clinical data and an operating system to make that data accessible and useful.
We aggregate and structure clinical records, pathology images and radiology scans to uncover phenotypic, therapeutic and outcomes data for every patient.
Our genomic tests analyze DNA and RNA data to understand a patient's tumor at a molecular level and uncover more personalized treatment options.
Our platform analyzes thousands of clinical and molecular data points supporting our partners with actionable insights for more impactful outcomes.
- Website
- www.tempus.com
Work with Tempus AI, Inc. on Scientist.com
For prices, more details, or to contact Tempus AI, Inc., visit Scientist.com.
Sign in to Scientist.com to open this supplier in your organization's marketplace.